[1]
“Efficacy and Safety of Sofosbuvir and Ribavirin in Treatment of Chronic Hepatitis C Infection G3 of Multi-Transfused Children Aged 4 To 12 Years; A Single Center Study ”, mfm, vol. 34, no. 7, Jul. 2023, Accessed: Dec. 27, 2025. [Online]. Available: https://medicalforummonthly.com/index.php/mfm/article/view/4409